BTK Inhibitors in Cancer Patients with COVID-19: “The Winner Will be the One Who Controls That Chaos” (Napoleon Bonaparte)

Overview of attention for article published in Clinical Cancer Research, July 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

So far, Altmetric has seen 2 news stories from 2 outlets.

COVID-19 has thrown a wrench in standard treatment protocols for patients with chronic lymphocytic leukemia (CLL).

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center.